⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HALO News
Halozyme Therapeutics, Inc.
Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda SC in Multiple European Markets
prnewswire.com
HALO
Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx to Support the Development of Subcutaneous Formulations for Two Additional Exclusive Targets Using its ENHANZE® Technology
prnewswire.com
HALO
Form 8-K
sec.gov
HALO
Halozyme Announces Appointment of Jim Daly to its Board of Directors
prnewswire.com
HALO
One Day Left: Nearly 185 Southern California Technology Leaders Registered for HMG Strategy's October 1 Summit on Enterprise AI, Cyber Resilience and Digital Transformation
globenewswire.com
BA
CMCSA
HALO
INGR
MAT
MSFT
DIS
SONY
Southern California Technology Leaders to Gather October 1 for HMG Strategy's C-Level Summit on Enterprise AI, Cyber Resilience and Digital Transformation; Complimentary Executive Passes Available
globenewswire.com
BA
CMCSA
HALO
MAT
Efgartigimod PH20 SC Market Driven by Rising Adoption and Expanding Therapeutic Opportunities, 2026-2034
globenewswire.com
HALO
Form 8-K
sec.gov
HALO
Form 8-K
sec.gov
HALO
Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033
prnewswire.com
HALO